OneWater Marine Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OneWater Marine Inc. (ONEW) on February 6, 2026, covering events occurring on February 2, 2026. The filing details the consummation of a material definitive agreement involving the sale of a subsidiary.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of equity interests in Ocean Bio-Chem Holdings, Inc. to Recochem Inc.
- Estimated Cash Proceeds: Approximately $50.0 million.
- Base Purchase Price: $55.0 million.
- Adjustments: Less an estimated $5.0 million for working capital and other adjustments at closing.
- Use of Proceeds: Repayment of a portion of the Company's outstanding debt.
- Final True-Up: A final working capital true-up will be determined 120 days after the Closing Date.
- Financial Statements: The filing references unaudited pro forma condensed consolidated financial statements as of and for the year ended September 30, 2025 (Exhibit 99.1), but does not provide specific revenue, profit, or cash flow figures within the text of this report.
Material Changes Versus Prior Period
The primary material change is the disposition of the Ocean Bio-Chem asset. The filing does not provide comparative operational metrics (revenue, margins, or debt levels) for the prior period within the text; investors must refer to the referenced pro forma statements in Exhibit 99.1 for quantitative impact analysis.
Guidance, Outlook, and Risks
- Management Commentary: The transaction is intended to reduce debt obligations. The Company and Buyer have agreed to customary indemnification provisions for breaches of covenants.
- Forward-Looking Statements: The report contains forward-looking statements regarding the sale and pro forma results, which are subject to uncertainties and risks detailed in the Company's Form 10-K and 10-Q filings.
- Risks and Contingencies: The final purchase price is contingent on a working capital true-up to be completed 120 days post-closing. The filing explicitly states that representations and warranties in the Purchase Agreement are for risk allocation and should not be relied upon as factual statements of the Company's condition.
Key Facts for Investor Verification
- Verify the final purchase price after the 120-day working capital true-up period.
- Review Exhibit 99.1 for the unaudited pro forma financial statements to assess the impact on the balance sheet and liquidity.
- Confirm the specific amount of debt to be repaid with the $50.0 million in proceeds.
- Examine the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and indemnification limitations.